Author

C. E. Bennett

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

C. C. Coss· 2 shared B. Ramaswamy· 1 shared C. Yates· 1 shared D. Nayak· 1 shared D. Stover· 1 shared H. S. Radomska· 1 shared J. Datta· 1 shared J. J. David· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. C. Coss

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide

J. S. Gray, S. A. Wani, S. Hussain, P. Huang, D. Nayak, M. D. Long, C. Yates, S. K. Clinton, C. E. Bennett, C. C. Coss, M. J. Campbell

This study shows that combining a novel ERβ ligand with Enzalutamide reduces MYC signaling and growth in advanced prostate cancer.

bioRxiv · Nov 15, 2023 · PreprintCancer Biology

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

J. Datta, N. Willingham, J. Manouchehri, P. Schnell, M. Sheth, J. J. David, M. Kassem, T. A. Wilson, H. S. Radomska, C. C. Coss, C. E. Bennett, R. K. Ganju, S. D. Sardesai, M. Lustberg, B. Ramaswamy, , M. A. Cherian

This study shows that selective ERβ agonists reduce viability of ER+ breast cancer cells and suggest their potential as a therapeutic strategy when combined with ER blockade.

bioRxiv · Jan 14, 2022Cancer Biology